Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial (Q57616705)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial	article

Statements

scholarly article

0 references

Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial (English)

0 references

0 references

hospitalization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

heart failure with reduced ejection fraction

1 reference

based on heuristic

inferred from title

ejection fraction

1 reference

based on heuristic

inferred from title

Aldo P. Maggioni

object named as

Aldo P. Maggioni

7

0 references

Mihai Gheorghiade

11

object named as

Mihai Gheorghiade

0 references

10

object named as

Faiez Zannad

0 references

8

object named as

Karl Swedberg

0 references

5

object named as

Mary J. Kwasny

0 references

Marvin A. Konstam

9

object named as

Marvin A. Konstam

0 references

Andrew P. Ambrosy

1

object named as

Andrew P. Ambrosy

0 references

Muthiah Vaduganathan

2

object named as

Muthiah Vaduganathan

0 references

4

object named as

Sadiya Khan

0 references

Angela J. Fought

6

object named as

Angela J. Fought

0 references

author name string

Mark D. Huffman

3

0 references

publication date

March 2012

0 references

European Journal of Heart Failure

0 references

14

0 references

3

0 references

302-311

0 references

Abnormal liver function in relation to hemodynamic profile in heart failure patients.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

LIVER FUNCTION IN CONGESTIVE HEART FAILURE.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

The liver in heart failure; relation of anatomical, functional, and circulatory changes

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Usefulness of serum albumin concentration for in-hospital risk stratification in frail, elderly patients with acute heart failure. Insights from a prospective, monocenter study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Serum albumin and mortality in acutely decompensated heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) progr

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Inadequate nutritional intake for daily life activity of clinically stable patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Wasting as independent risk factor for mortality in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Prognosis and therapy approaches of cardiac cachexia

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Hypoalbuminaemia and incident heart failure in older adults

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS007

21 January 2018

Identifiers

10.1093/EURJHF/HFS007

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57616705&oldid=2072847066"